AstraZeneca Pharma India Ltd. - Research Center
506820 ASTRAZEN Group (A) BSE data
Add to watchlist
| Results |
Quarterly
|
| Statement | |
| More |
Quarterly results in brief
(Rs crore)
| Sep' 20 | Jun' 20 | Mar' 20 | Dec' 19 | Sep' 19 | |
|---|---|---|---|---|---|
| Sales | 209.48 | 193.58 | 194.90 | 223.86 | 208.48 |
| Operating profit | 35.76 | 28.57 | 14.79 | 36.76 | 33.56 |
| Interest | 0.28 | 0.27 | 0.27 | 0.27 | 0.28 |
| Gross profit | 40.19 | 30.95 | 17.90 | 39.95 | 36.44 |
| EPS (Rs) | 10.54 | 7.45 | 3.83 | 10.68 | 5.77 |
Quarterly
results in details
| Sep' 20 | Jun' 20 | Mar' 20 | Dec' 19 | Sep' 19 | |
|---|---|---|---|---|---|
| Other income | 4.71 | 2.65 | 3.38 | 3.46 | 3.16 |
| Stock adjustment | -15.72 | 4.59 | -24.02 | -17.09 | -2.71 |
| Raw material | 23.98 | 20.85 | 16.53 | 21.65 | 13.28 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 55.64 | 56.35 | 81.25 | 52.55 | 52.16 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | 11.49 | 9.24 | 13.06 | 11.70 | 14.01 |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 98.33 | 73.97 | 93.30 | 118.29 | 98.18 |
| Provisions made | - | - | - | - | - |
| Depreciation | 4.62 | 4.56 | 4.54 | 4.77 | 4.64 |
| Taxation | 9.23 | 7.75 | 3.77 | 8.48 | 17.38 |
| Net profit / loss | 26.34 | 18.63 | 9.58 | 26.70 | 14.42 |
| Extra ordinary item | - | - | - | - | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | 17.07 | 14.76 | 7.59 | 16.42 | 16.10 |
| GPM (%) | 18.76 | 15.77 | 9.03 | 17.58 | 17.22 |
| NPM (%) | 12.30 | 9.50 | 4.83 | 11.75 | 6.81 |
© 2021 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis